Cardiovascular and glucose-lowering medication use among older adults: results from 9-year follow-up of the FINGER trial

Abstract

Aim: To study cardiovascular and glucose-lowering medication use, its trajectories along with age, and differences in use between study (lifestyle intervention vs. control), sex, and age groups among older adults at risk of cognitive impairment. Findings: Cardiovascular and glucose-lowering medication use was common and increased over time. The use was fairly similar between different study and sex groups, but older participants used more cardiovascular medication compared to younger. Message: The use of cardiovascular and glucose-lowering medication increases along with age among older people at risk of cognitive impairment which reflects the increasing cardiometabolic morbidity, management of the risks and diseases via medication and possible changes in medical practices.